Department of Microbiology and Immunology
Dr. Atkinson Awarded R01 from NIH/NHLBI
Dr. Carl Atkinson was awarded an R01 grant from NIH/NHLBI titled “Complement driven innate and adaptive autoreactivity in lung transplantation.” Lung transplant is an established therapy for patients suffering from end stage lung disease. The major obstacle to survival is obliterative bronchiolitis. The Atkinson Lab will investigate inhibition of complement immune pathways to improve outcomes.